מכפיל P/S עתידי scpharmaceuticals.com (SCPH)

scPharmaceuticals Inc. complies with basic environmental standards by outsourcing pump production to external partners. The projected price-to-sales ratio visualizes market expectations, where 6.00 shows the current value of the metric. scPharmaceuticals Inc. is implementing the Furoscix system for home treatment of heart failure, reducing hospital expenses. Its status as an innovator and the trust of cardiologists confirm the high value of the therapy for patients.

This indicator compares the current market capitalization of scPharmaceuticals Inc. (SCPH) with projected revenue to determine the premium for future growth and the potential acquisition value of the asset. Amid the expansion of the home heart failure treatment segment, the estimated forward P/S reflects how the market values the effectiveness of reducing hospitalization costs, allowing investors to identify business undervaluation or operational risks.